BlackRock’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54M | Buy |
|
|||||
|
2025
Q1 | $1.14M | Sell |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $526K | Buy |
|
|||||
|
2024
Q2 | $579K | Buy |
|
|||||
|
2024
Q1 | $658K | Sell |
|
|||||
|
2023
Q4 | $745K | Sell |
|
|||||
|
2023
Q3 | $889K | Sell |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $942K | Buy |
|
|||||
|
2022
Q4 | $100K | Sell |
|
|||||
|
2022
Q3 | $124K | Sell |
|
|||||
|
2022
Q2 | $114K | Sell |
|
|||||
|
2022
Q1 | $317K | Buy |
|
|||||
|
2021
Q4 | $478K | Buy |
|
|||||
|
2021
Q3 | $743K | Sell |
|
|||||
|
2021
Q2 | $747K | Sell |
|
|||||
|
2021
Q1 | $4.88M | Buy |
|
|||||
|
2020
Q4 | $3.56M | Buy |
|
|||||
|
2020
Q3 | $4.85M | Buy |
|
|||||
|
2020
Q2 | $5.86M | Buy |
|
|||||
|
2020
Q1 | $283K | Buy |
|
|||||
|
2019
Q4 | $370K | Sell |
|
|||||
|
2019
Q3 | $470K | Sell |
|
|||||
|
2019
Q2 | $441K | Sell |
|
|||||
|
2019
Q1 | $739K | Sell |
|
|||||
|
2018
Q4 | $685K | Buy |
|
|||||
|
2018
Q3 | $1.26M | Sell |
|
|||||
|
2018
Q2 | $1.59M | Buy |
|
|||||
|
2018
Q1 | $998K | Buy |
|
|||||
|
2017
Q4 | $465K | Buy |
|
|||||
|
2017
Q3 | $541K | Buy |
|
|||||
|
2017
Q2 | $356K | Sell |
|
|||||
|
2017
Q1 | $4.53M | Buy |
|
|||||
|
2016
Q4 | $93K | Hold |
|
|||||
|
2016
Q3 | $102K | Hold |
|
|||||
|
2016
Q2 | $92K | Buy |
|
|||||
|
2016
Q1 | $1K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $113K | Hold |
|
|||||
|
2015
Q2 | $124K | Buy |
|